Pfaeffli Dale Leila, Whittaker Robyn, Jiang Yannan, Stewart Ralph, Rolleston Anna, Maddison Ralph
National Institute for Health Innovation, University of Auckland, Auckland, New Zealand.
J Med Internet Res. 2015 Oct 21;17(10):e237. doi: 10.2196/jmir.4944.
BACKGROUND: Mobile technology has the potential to deliver behavior change interventions (mHealth) to reduce coronary heart disease (CHD) at modest cost. Previous studies have focused on single behaviors; however, cardiac rehabilitation (CR), a component of CHD self-management, needs to address multiple risk factors. OBJECTIVE: The aim was to investigate the effectiveness of a mHealth-delivered comprehensive CR program (Text4Heart) to improve adherence to recommended lifestyle behaviors (smoking cessation, physical activity, healthy diet, and nonharmful alcohol use) in addition to usual care (traditional CR). METHODS: A 2-arm, parallel, randomized controlled trial was conducted in New Zealand adults diagnosed with CHD. Participants were recruited in-hospital and were encouraged to attend center-based CR (usual care control). In addition, the intervention group received a personalized 24-week mHealth program, framed in social cognitive theory, sent by fully automated daily short message service (SMS) text messages and a supporting website. The primary outcome was adherence to healthy lifestyle behaviors measured using a self-reported composite health behavior score (≥3) at 3 and 6 months. Secondary outcomes included clinical outcomes, medication adherence score, self-efficacy, illness perceptions, and anxiety and/or depression at 6 months. Baseline and 6-month follow-up assessments (unblinded) were conducted in person. RESULTS: Eligible patients (N=123) recruited from 2 large metropolitan hospitals were randomized to the intervention (n=61) or the control (n=62) group. Participants were predominantly male (100/123, 81.3%), New Zealand European (73/123, 59.3%), with a mean age of 59.5 (SD 11.1) years. A significant treatment effect in favor of the intervention was observed for the primary outcome at 3 months (AOR 2.55, 95% CI 1.12-5.84; P=.03), but not at 6 months (AOR 1.93, 95% CI 0.83-4.53; P=.13). The intervention group reported significantly greater medication adherence score (mean difference: 0.58, 95% CI 0.19-0.97; P=.004). The majority of intervention participants reported reading all their text messages (52/61, 85%). The number of visits to the website per person ranged from zero to 100 (median 3) over the 6-month intervention period. CONCLUSIONS: A mHealth CR intervention plus usual care showed a positive effect on adherence to multiple lifestyle behavior changes at 3 months in New Zealand adults with CHD compared to usual care alone. The effect was not sustained to the end of the 6-month intervention. A larger study is needed to determine the size of the effect in the longer term and whether the change in behavior reduces adverse cardiovascular events. TRIAL REGISTRATION: ACTRN 12613000901707; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364758&isReview=true (Archived by WebCite at http://www.webcitation.org/6c4qhcHKt).
背景:移动技术有潜力以适度成本提供行为改变干预措施(移动健康)以降低冠心病(CHD)风险。以往研究主要关注单一行为;然而,心脏康复(CR)作为冠心病自我管理的一部分,需要应对多种风险因素。 目的:旨在研究通过移动健康提供的综合心脏康复项目(Text4Heart)在常规护理(传统心脏康复)基础上,提高对推荐生活方式行为(戒烟、体育活动、健康饮食和适度饮酒)依从性的有效性。 方法:在新西兰诊断为冠心病的成年人中进行了一项双臂、平行、随机对照试验。参与者在医院招募,并鼓励他们参加基于中心的心脏康复(常规护理对照)。此外,干预组接受了一个为期24周的个性化移动健康项目,该项目以社会认知理论为框架,通过全自动每日短信服务(SMS)短信和一个支持网站发送。主要结局是在3个月和6个月时使用自我报告的综合健康行为评分(≥3)衡量的对健康生活方式行为的依从性。次要结局包括临床结局、药物依从性评分、自我效能、疾病认知以及6个月时的焦虑和/或抑郁。基线和6个月随访评估(非盲法)均亲自进行。 结果:从两家大型都市医院招募的符合条件的患者(N = 123)被随机分为干预组(n = 61)或对照组(n = 62)。参与者主要为男性(100/123,81.3%),新西兰欧洲人(73/123,59.3%),平均年龄59.5(标准差11.1)岁。在3个月时,观察到干预组在主要结局上有显著的治疗效果(调整后比值比2.55,95%置信区间1.12 - 5.84;P = 0.03),但在6个月时没有(调整后比值比1.93,95%置信区间0.83 - 4.53;P = 0.13)。干预组报告的药物依从性评分显著更高(平均差值:0.58,95%置信区间0.19 - 0.97;P = 0.004)。大多数干预参与者报告阅读了所有短信(52/61,85%)。在6个月的干预期内,每人访问网站的次数从零到100不等(中位数为3)。 结论:与单独的常规护理相比,移动健康心脏康复干预加常规护理在3个月时对新西兰冠心病成年患者多种生活方式行为改变的依从性显示出积极效果。这种效果在6个月干预结束时未持续。需要进行更大规模的研究来确定长期效果的大小以及行为改变是否能减少不良心血管事件。 试验注册:ACTRN 12613000901707;https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=364758&isReview=true(由WebCite存档于http://www.webcitation.org/6c4qhcHKt)
JMIR Mhealth Uhealth. 2021-9-24
J Med Internet Res. 2016-8-5
J Multidiscip Healthc. 2025-3-19
iScience. 2024-8-19
Eur Heart J. 2013-11-25
Cochrane Database Syst Rev. 2013-8-20